{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:34:10Z","timestamp":1787502850036,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.thromres.2019.03.018","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T05:36:53Z","timestamp":1553751413000},"page":"54-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Elevated plasma levels of soluble C-type lectin-like receptor 2 (CLEC2) in patients with thrombotic microangiopathy"],"prefix":"10.1016","volume":"178","author":[{"given":"Yoshiki","family":"Yamashita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Mastumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ikejiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Ohishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsue","family":"Suzuki-Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9021-8633","authenticated-orcid":false,"given":"Hideo","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2019.03.018_bb0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12959-018-0168-2","article-title":"Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy","volume":"16","author":"Wada","year":"2018","journal-title":"Thromb. J."},{"key":"10.1016\/j.thromres.2019.03.018_bb0010","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1055\/s-0034-1395154","article-title":"Natural history of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome","volume":"40","author":"Wada","year":"2014","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2019.03.018_bb0015","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2019.03.018_bb0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2169\/internalmedicine.49.2706","article-title":"Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998\u20132008","volume":"49","author":"Fujimura","year":"2010","journal-title":"Intern. Med."},{"key":"10.1016\/j.thromres.2019.03.018_bb0025","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.290.10.1360","article-title":"Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression","volume":"290","author":"Garg","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2019.03.018_bb0030","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.thromres.2019.03.018_bb0035","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJM198212023072306","article-title":"Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura","volume":"307","author":"Moake","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2019.03.018_bb0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ajh.2830390106","article-title":"Plasma Thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation","volume":"39","author":"Wada","year":"1992","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2019.03.018_bb0045","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/107602969800400309","article-title":"Increased plasma soluble-adhesion molecules in patients with thrombotic thrombocytopenic purpura and those with disseminated intravascular coagulation","volume":"4","author":"Shimura","year":"1998","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2019.03.018_bb0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s12185-010-0732-4","article-title":"Elevated Von Willebrand factor propeptide for the diagnosis of thrombotic microangiopathy and for predicting a poor outcome","volume":"93","author":"Ito-Habe","year":"2011","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.thromres.2019.03.018_bb0055","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.thromres.2013.11.023","article-title":"Elevated plasma levels of soluble platelet glycoprotein VI (GPVI) in patients with thrombotic microangiopathy","volume":"133","author":"Yamashita","year":"2014","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2019.03.018_bb0060","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s12185-014-1676-x","article-title":"Elevated soluble platelet glycoprotein VI is a useful marker for DVT in postoperative patients treated with edoxaban","volume":"100","author":"Aota","year":"2014","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.thromres.2019.03.018_bb0065","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/1076029615604047","article-title":"Elevated soluble platelet glycoprotein VI levels in patients after living donor liver transplantation","volume":"23","author":"Takahashi","year":"2017","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2019.03.018_bb0070","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1161\/STROKEAHA.110.602532","article-title":"Soluble glycoprotein VI is raised in the plasma of patients with acute ischemic stroke","volume":"42","author":"Al-Tamimi","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2019.03.018_bb0075","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1182\/blood-2010-08-301523","article-title":"Coagulation-induced shedding of platelet glycoprotein VI mediated by factor Xa","volume":"117","author":"Al-Tamimi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2019.03.018_bb0080","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood-2005-05-1994","article-title":"A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2","volume":"107","author":"Suzuki-Inoue","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2019.03.018_bb0085","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Towards a definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.03.018_bb0090","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3109\/09537104.2015.1021319","article-title":"Measurement of soluble C-type lectin-like receptor 2 in human plasma","volume":"26","author":"Kazama","year":"2015","journal-title":"Platelet"},{"key":"10.1016\/j.thromres.2019.03.018_bb0095","unstructured":"Hosoka Y, Naitoh K, Honda M: Novel platelet activation marker and method for determination thereof, European Patent Application publication No. EP2000802 A1, published on December 10, 2007."},{"key":"10.1016\/j.thromres.2019.03.018_bb0100","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2005.05420.x","article-title":"FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay","volume":"129","author":"Kokame","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2019.03.018_bb0105","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.thromres.2006.04.007","article-title":"Decreased ADAMTS13 activity in plasma from patients with thrombotic thrombocytopenic purpura","volume":"119","author":"Kobayashi","year":"2007","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2019.03.018_bb0110","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1538-7836.2006.01942.x","article-title":"Elevated levels of soluble fibrin or D-dimer indicate high risk of thrombosis","volume":"4","author":"Wada","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.03.018_bb0115","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.thromres.2011.10.011","article-title":"Plasma ADAMTS13, von Willebrand factor (VWF) and VWF propeptide profiles in patients with DIC and related diseases","volume":"129","author":"Habe","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2019.03.018_bb0120","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1537-2995.2002.00100.x","article-title":"Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity","volume":"42","author":"Mori","year":"2002","journal-title":"Transfusion"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384819301793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384819301793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:39:10Z","timestamp":1758735550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384819301793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":24,"alternative-id":["S0049384819301793"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2019.03.018","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated plasma levels of soluble C-type lectin-like receptor 2 (CLEC2) in patients with thrombotic microangiopathy","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2019.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}